Meeting Report

Diagnosis and Treatment of Adenocarcinomas and Squamous Cell Carcinomas of the Lung

Presented by Millie Das,(1) MD, and Alison Holmes Tisch,(2) MSN, RN, ANP-BC, AOCNP®

(1)Stanford University and VA Palo Alto Health Care System; (2)Stanford Cancer Center

Presenters’ disclosures of potential conflicts of interest are found at the end of this article.


J Adv Pract Oncol 2017;8:267–272 | https://doi.org/10.6004/jadpro.2017.8.3.9 | © 2017 Harborside Press®


  

ABSTRACT

Following years in which there were only modest gains in treatment options for non-small cell lung cancer, recognition of targetable mutations and immunogenicity of lung cancer now impact treatment decisions.


For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me